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Abstract
Background: Type 2 DM patients usually had poor prognosis for CAD. MPS with SPECT
has been extensively used in CAD detection and it’s application among type 2 DM
population is still under study with promising result. In the Philippines, there are no
current available data regarding this matter. Methodology: This was a cross sectional
analytical study of randomly selected Filipino patients without previous cardiac
events in whom MPS using Thallium-201 were performed over a 24-month period.
Association of myocardial ischemia was compared using logistic regression analysis
based on total summed stress score (SSS) values. Results: Total of 208 patients (104
type 2 DM and 104 non-type 2 DM) who underwent stress or pharmacologic MPS
using Thallium-201 were included in the study. Majority of the subjects were male.
Abnormal 2D echo result and lower EF were significantly present among type 2 DM
group (p = 0.044, 0.0005). Hypertension was more prominent among the list of
co-morbidities and has significant relationship with type 2 DM group (p = 0.025). The
distribution of myocardial ischemia among type 2 DM group with insignificant, mildly
abnormal, and moderate to severely abnormal; were 60.6%, 12.5%, and 26.9%,
respectively. The presence of having significant CAD (SSS>3) was associated with the
type 2 DM group with odds ratio of 2.57 (95% CI: 1.38-4.78, p = 0.003) Conclusion:
The current study has shown that Filipino type 2 DM patients without previous cardiac
events are likely to have significant and more severe scintigraphic evidence of CAD
than their non-type 2 DM counterpart.
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Diabetes mellitus (DM) is a significant health problem with great importance [1]. It
has an estimated worldwide prevalence of 200 million as of 2007 and projected to
balloon to 300 million in 2025 [2]. In the Philippines, its prevalence as of 2008 was
17.8%, which translates to 1 out of every 5 Filipinos potentially have type 2 DM [3].
Coronary artery disease (CAD) is the leading cause of death among type 2 DM patients
[1], [4]-[7]. Myocardial ischemia in these patients are usually silent and in advanced
stage once they clinically manifest [4]-[5], [8]-[9]. The risk for patients with type 2
DM to have myocardial infarction (MI) is 2-4 folds than their non-DM counterparts [5]-
[6], [10]. In addition, they generally have a less favorable response to revascularization
and have reduced overall long-term survival [4], [9]. However, in the Philippines, early
detection of CAD in these population is usually delayed by undergoing screening for
CAD thru less sensitive but widely available diagnostic tool in out patient department
setting like ECG. Further testing are often done for definitive diagnosis of CAD [6], [11].
The role of single-photon emission computed tomography (SPECT) in evaluation
for myocardial ischemia has been extensively studied [1], [4], [6]-[7]. In general, the
sensitivity and specificity of SPECT for CAD detection are 86% and 74%, respectively
[6, 11]. Its accuracy between patients with and without type 2 DM are also comparable
[4], [11]. Although not the “gold” standard for the detection of CAD, nuclear imaging
with SPECT offers several advantages over coronary angiography since it is less expen-
sive, has lesser complications due to its non-invasive nature, and provides information
about physiologic significance of flow-limiting CAD [6], [11]. Current opinion regarding
evaluation of CAD in type 2 DM patients is to recommend stress myocardial perfusion
scintigraphy (MPS) [7]. The usefulness of this approach is still under study, however
therewere promising results [1], [4]-[5], [7], [11]. In the Philippines, there are no current
available data regarding this matter.
2. Objectives of the Study
This study aims to determine the association of type 2 DM and the presence of myocar-
dial ischemia among Filipino type 2 DM patients who underwent stress or pharma-
cologic stress MPS using Thallium-201 so that preventive measures maybe taken in
order to reduce morbidity of CAD. This study also determines the distribution of type
2 DM patients with insignificant, mildly abnormal, and moderate to severely abnormal
ischemia.
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3. Materials and Methods
3.1. Ethical considerations
This study was conducted in compliance with the ethical principles set forth in the Dec-
laration of Helsinki. Prior to the study, the protocol was reviewed and approved by the
Philippine Heart Center Institutional Ethics Review Board (PHC IERB). The investigator
request for the waiver of informed consent due to difficulty of obtaining individual
authorization since the last contact with research subjects. The risk to the subject’s
privacy was minimal and no sensitive information were obtained. The investigator
ensured that subject anonymity was maintained.
3.2. Study population and patient selection
This was a cross sectional analytical study of 208 Filipino patients (104 type 2 DM, 104
non-type 2 DM), referred for exercise stress or pharmacologic stress (dipyridamole)
MPS using Thallium-201 to the Department of Nuclear Medicine of the Philippine Heart
Center (PHC) in Quezon City, Philippines for a period of 24 months, from, June 1, 2014
to May 31, 2016. The subjects included were; 1) type 2 DM and non-DM Filipino patients
and 2) adult patients > 19 years old. Patients with these following conditions, namely;
1) prior history of MI, 2) previous history of coronary artery bypass graft (CABG)
or percutaneous transluminal coronary angioplasty (PTCA) operations, 3) critically-ill
patients, 4) valvular heart disease (VHD), and 6) pregnant patients, were excluded in
the study. Sample size calculation for this study was made using STATA SE version 13
software. The minimum sample size computed was > 208, based on % ischemia of
diabetic and non-diabetic patients, 44.8% and 25.4% [1] respectively, with alpha =
5% and power of 80%.
3.3. Study maneuver
A chart review of Filipino patients who underwent stress or pharmacologic (dipyri-
damole) stress MPS using Thallium-201 was made. Eligible subjects were selected
based on the existing electronic medical records. A total of 1510 patients undergo
MPS for the said inclusive dates, were 638 had MPS using Thallium-201. From 638
eligible patients, they were dichotomized into two groups, type 2 DM and non-type 2
DM groups, then undergo randomization, each having 104 subjects. Demographic data,
patients risk factors and presence of ischemia based on summed stress score (SSS),
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were obtained using prepared data collection form. For this study, diabetic patients
were defined as individuals who had established diabetic history, taking hypoglycemic
agent (either oral or insulin). Philippine Heart Center Nuclear Medicine standard pro-
tocol for stress and pharmacologic stress MPS using Thallium-201 was used.
3.4. Visual analysis of MPS
All MPS studies were analysed by two experience observers using a 17-segment
scheme. Thallium-201 uptake were scored using a five-point scale (0 = normal, 1 =
mildly decreased, 2 = moderately decreased, 3 = severely decreased, and 4 = absent).
The summed stress score (SSS) is commonly used as semiquantitative technique that
combines the extent and severity of perfusion abnormalities into a single measure.
More extensive perfusion abnormalities are associated with more severe CAD [16].
SSS >3 is synonymous with having significant CAD [12].
3.5. Statistical analysis
Data analysis was done using STATA SE version 13. Quantitative variables were sum-
marized as mean and standard deviation, while qualitative variable was tabulated as
frequency and percentage. Association between type 2 DM and presence of myocar-
dial ischemia were estimated and tested using logistic regression analysis with level
of significance set at 5%.
4. Results and Discussion
A total of 208 patients (104 type 2 DM, 104 non-type 2 DM) were included in the
study. The mean age was 59.1 + 10.6 years and 57.2 + years for type 2 DM and non-
type 2 DM group, respectively. Male subjects dominate the study subjects (58%).
ECG findings of ischemia were comparable among the two groups. Abnormal 2D echo
results and lower ejection fraction (EF) values were significantly prominent in the
type 2 DM group (p = 0.044, 0.0005). Hypertension tops the list among the list of co-
morbidities andwas significantly higher in the type 2 DM group (p = 0.025). Angiotensin
receptor blocker/inhibitor (ACE/ARB) as BP lowering drugwas usedmore often by type
2 DM group (p = 0.017). Other baseline and clinical characteristics had no significant
difference among the groups (Table 1).
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Table 1: Comparison of Baseline Characteristics.
The distribution of type 2 DM patients with insignificant, mildly abnormal, and
moderate to severely abnormal myocardial ischemia based on SSS values were 60.6%
(63/104), 12.5% (13/104), and 26.9% (28/104), respectively. Higher moderate to
severely abnormal myocardial ischemia was seen in the type 2 DM group (Figure
1).
Presence of scintigraphic evidence of myocardial ischemia or risk of having signifi-
cant CAD was significantly associated with the type 2 DM group with an odds ratio of
2.57 (95% CI: 1.38-4.78, p = 0.003) (Table 2).
Table 2: Association between type 2 DM and presence of myocardial ischemia.
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Figure 1: Distribution of myocardial ischemia among the study subjects..
The results of this recent study showed that the risk of having significant CAD
expressed in SSS among Filipino patients without previous cardiac events are signifi-
cantly higher among the type 2 DM group. The frequency and severity of myocardial
ischemia, abnormal 2D echo result and low EF values are also more prominent in this
group. Among the risk factors examined for CAD, hypertension showed significant
relationship with type 2 DM. These findings are in agreement with those reported by
Wackers, et al., DeLuca et al., and Shmendi, et al., using Technetium 99m-Sestamibi
[4], [8], [11]. In a multi-centered randomized controlled trial study by Wackers, et. al.,
involving 1123 subjects; silent myocardial ischemia occurred in > 20% asymptomatic
type 2 DM patients [4]. DeLuca et. al. study comprising of 836 patients, showed
that the prevalence of silent myocardial ischemia detected by MPS among type 2
DM patients without known CAD were significantly higher than their non-type 2 DM
counterpart, 34% (67/196) versus 14% (89/640), respectively [8]. In a retrospective
chart review of 340 patients, Shmendi et al., demonstrated that the prevalence of
more extensive myocardial ischemia using stress or pharmacologic stress MPS was
significantly associatedwith type 2 DMpatients than thosewithout the disease (85.6%
versus 68%; odds ratio of 2.81, p = <0.01) [11].
Screening for CAD in this type 2 DM population are usually hampered by the less
sensitive and specific non-invasive diagnostic modalities. ECG is the most widely use
technique for risk stratification of patients with suspected CAD [13]. However, studies
have showed that resting and exercise ECG were not the most sensitive techniques
with low diagnostic accuracy for CAD detection among type 2 DM patients [6], [11]. The
appearance of transient ST segment depression, which is the hallmark for myocardial
ischemia, is affected by factors other than myocardial ischemia itself. These factors
and the fact that ST-T changes occur late in the ischemic cascade, makes exercise ECG
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a modest diagnostic accuracy for CAD detection [13]. The sensitivity and specificity of
exercise ECG test for CAD detection among type 2 DM patients were 47% and 81%
respectively [14]. Another non-invasive diagnostic modality is the stress echocardio-
graphy. Exercise and pharmacologic stress ECHO are widely accessible, less expensive
and typically well-tolerated. This test is appropriate for symptomatic patients with
intermediate pretest probability of CAD and contraindications to regular treadmill stress
testing. For CAD detection, exercise stress echo has a sensitivity and specificity of 79-
85% and 72%-87%, for general population; 82% and 54%, respectively for type 2 DM
population [14]-[15]. There are limited data that specifically address the utility of stress
echocardiography in CAD detection among type 2 DM patients [14].
MPSwith SPECT is an essential non-invasive diagnostic tool in CAD detection and risk
stratification. Although not suggested as a screening tools for CAD detection among
type 2 DM Filipino patients, it has significant value in identifying those at risk for
CAD and thus in need of more aggressive management [1], [7], [11]. This is important
because once CAD in type 2 DM patients becomes symptomatic, these patients will
face significant morbidity and mortality. MPS, with the newer detectors, has one of the
highest sensitivity and acceptable specificity among the cardiac non-invasive diagnos-
tic tool and has several advantages over the gold standard, coronary angiography in
CAD detection in terms of economics and risk of complication [16]. Compared to stress
ECG and 2D echo, MPS also has the advantage to plot areas of reversible ischemia
with their corresponding affected vascular supply. The result of this study suggested
aggressive CAD screening among type 2 DM Filipino patients without previous cardiac
events using high sensitivity non-invasive diagnostic tool like MPS for early detection,
prevention and treatment of CAD.
4.1. Limitation of the study
The retrospective data collection of this study was a limitation, since the accuracy of
the data gathered was dependent on the available medical records. There was also no
accurate information about the duration of type 2 DM and degree of glycemic control.
Lastly, this studywas also limited by referral bias, sincemajority of the patients referred
for MPS in this institution were based on symptoms and majority had multiple CAD risk
factors.
DOI 10.18502/kss.v3i6.2405 Page 574
IRCHE 2017
5. Conclusion and Recommendation
The current study has shown that Filipino type 2 DM patients without previous cardiac
events are likely to have significant and more severe scintigraphic evidence of CAD
than their non-type 2 DM counterpart. This study suggest aggressive CAD screening
among this population for early detection, prevention and treatment of CAD. Further
study are needed with emphasis on glycemic control and duration of type 2 diabetes in
relation to MPS defects. Lastly, this present study suggest future incorporation of MPS
in clinical practice guidelines for CAD detection among Filipino type 2 DM population.
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